Gilead to build its EU CAR-T manufacturing facility at Amsterdam airport

In addition to a new manufacturing site in Amsterdam, Kite has acquired facilities in Santa Monica, California, and Gaithersburg, Maryland, for R&D and manufacturing for CAR-T treatments. (Kite)

Speed is of the essence when it comes to manufacturing CAR T drugs—personalized treatments in which immune cells are engineered to recognize and destroy patients’ cancers. With that in mind, Gilead will locate a new European manufacturing site for its CAR-T therapy Yescarta at an airport in the Netherlands.